🇺🇸 FDA
Patent

US 8614179

Antibacterial combination therapy for the treatment of gram positive bacterial infections

granted A61KA61K31/336A61K31/4174

Quick answer

US patent 8614179 (Antibacterial combination therapy for the treatment of gram positive bacterial infections) held by E-Therapeutics PLC expires Mon Dec 19 2033 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
E-Therapeutics PLC
Grant date
Tue Dec 24 2013 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Dec 19 2033 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
4
CPC classes
A61K, A61K31/336, A61K31/4174, A61K31/42, A61K38/12